-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IdW40TgW+pKlUE7xfNUAYrLtrUt/cZSz3fmiNyehgWg40mWYL+cvg91XpzOtH04j nx4WU6J76v3CZUdBUY4s9Q== 0000950137-02-004564.txt : 20020820 0000950137-02-004564.hdr.sgml : 20020820 20020820083355 ACCESSION NUMBER: 0000950137-02-004564 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020820 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20020820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO CO CENTRAL INDEX KEY: 0000820096 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 382799573 STATE OF INCORPORATION: MI FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19725 FILM NUMBER: 02743384 BUSINESS ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 BUSINESS PHONE: 6166738451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 8-K 1 c71483e8vk.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2002 PERRIGO COMPANY -------------------------------------------------- (Exact name of registrant as specified in charter) MICHIGAN 0-19725 38-2799573 - --------------- ------------ ------------------- (State of other (Commission (I.R.S. Employer Jurisdiction of File Number) Identification Incorporation) Number) 515 Eastern Avenue, Allegan, Michigan 49010 - ------------------------------------------ ----------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (616) 673-8451 - -------------- Item 7(c). Exhibits Exhibit 99 Perrigo Company Extends Share Repurchase Program press release. ITEM 9. Regulation FD Disclosure On August 19, 2002, the Board of Directors of the Perrigo Company authorized the repurchase of an additional $20 million of the Company's common stock. The extended share repurchase program press release is Exhibit 99. SIGNATURES Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERRIGO COMPANY (Registrant) By: /s/ Douglas R. Schrank ------------------------------- Dated: August 20, 2002 Douglas R. Schrank Executive Vice President and Chief Financial Officer (Principal Accounting and Financial Officer) Exhibit Index Exhibit 99 - Perrigo Company Extends Share Repurchase Program press release. EX-99 3 c71483exv99.txt PRESS RELEASE EXHIBIT 99 FOR IMMEDIATE RELEASE Ernest J. Schenk, Manager, Investor Relations and Communication (616)673-9212 E-mail: investor@perrigo.com PERRIGO COMPANY EXTENDS SHARE REPURCHASE PROGRAM ALLEGAN, Michigan -- August 20, 2002 -- The Perrigo Company (Nasdaq: PRGO) today announced that its Board of Directors has authorized the repurchase of an additional $20 million of the Company's common stock under its ongoing share repurchase program. As of August 15, 2002, Perrigo had 70,688,467 common shares outstanding. Under share repurchase authorizations since November 2000, Perrigo has repurchased approximately 4.5 million shares at a cost of approximately $52 million. Perrigo Company is the nation's largest manufacturer of over-the-counter (non-prescription) pharmaceutical and nutritional products sold by supermarket, drug, and mass merchandise chains under their own labels. The Company's products include over-the-counter pharmaceuticals such as analgesics, cough and cold remedies, gastrointestinal, and feminine hygiene products, and nutritional products, such as vitamins, nutritional supplements and nutritional drinks. Visit Perrigo on the Internet (www.perrigo.com). Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. Please see the "Cautionary Note Regarding Forward-Looking Statements" on pages 24-29 of the Company's Form 10-K for the year ended June 30, 2001 for a discussion of certain important factors that relate to forward-looking statements contained in this press release. In addition, the Company's future results may be affected by the impact of events flowing from the September 11, 2001 terrorist attacks, current economic conditions in the United States, retailers' financial difficulties or current cough/cold/flu seasonal trends. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Unless otherwise required by applicable securities laws, the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. ### -----END PRIVACY-ENHANCED MESSAGE-----